Psoriatic arthritis (disorder)

PEAC: Pathobiology of Early Arthritis Cohort

Year Started: 2008

Prospective, observational study in patients with early symptomatic inflammatory arthritis (http://www.peac-mrc.mds.qmul.ac.uk/). Biological samples (synovial tissue & fluids) are collected at two timepoints - Baseline & Follow-up (6 month), please note figures for baseline samples are represented (6 month sample availability on request). Demographic & clinical data is available & collected at 5 timepoints over a 1-year follow-up period (Baseline, 3, 6, 9 & 12 months). Current recruitment status for Psoriatic Arthritis cohort is 44 patients (1st April 2019).



Access:
Closed to access
Type:
Cohort
Status:
In progress
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Genomic datasets 0 - 3 months
Imaging data 0 - 3 months
Pathology records 0 - 3 months
Physiological/biochemical measurements 0 - 3 months
Quality indicators 0 - 3 months
Treatment records 0 - 3 months
Donor Ethnicity 0 - 3 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 75% -99%
Plasma -60°C to -85°C N/A Affected 75% -99%
RNA -60°C to -85°C N/A Affected 51 - 75%
Serum -60°C to -85°C N/A Affected 75% -99%
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 75% -99%
Urine -60°C to -85°C N/A Affected 75% -99%

Undifferentiated inflammatory arthritis (disorder)

PEAC: Pathobiology of Early Arthritis Cohort

Year Started: 2008

Prospective, observational study in patients with early symptomatic inflammatory arthritis (http://www.peac-mrc.mds.qmul.ac.uk/). Biological samples (synovial tissue & fluids) are collected at two timepoints - Baseline & Follow-up (6 month), please note figures for baseline samples are represented (6 month sample availability on request). Demographic & clinical data is available & collected at 5 timepoints over a 1-year follow-up period (Baseline, 3, 6, 9 & 12 months). Current recruitment status for the Undifferentiated/Non-Inflammatory Arthritis cohort is 65 patients (1st April 2019).



Access:
Closed to access
Type:
Cohort
Status:
In progress
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Genomic datasets 0 - 3 months
Imaging data 0 - 3 months
Pathology records 0 - 3 months
Quality indicators 0 - 3 months
Treatment records 0 - 3 months
Donor Ethnicity 0 - 3 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 75% -99%
Plasma -60°C to -85°C N/A Affected 75% -99%
RNA -60°C to -85°C N/A Affected 51 - 75%
Serum -60°C to -85°C N/A Affected 75% -99%
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 75% -99%
Urine -60°C to -85°C N/A Affected 75% -99%

Psoriatic arthritis (disorder)

PSABRE: Psoriatic Arthritis Pathobiology and its Relationship with Clinical Disease Activity

Year Started: 2015

Exploratory, prospective, observational, single site study. To explore the evolution of clinical disease characteristics in patients with psoriatic arthritis who have failed standard non-biologic therapy. Biological samples (synovial & skin tissues, & fluids) collected at multiple timepoints (details available on request), please note figures for baseline samples are represented (availability of samples from other timepoints on request). Demographic & clinical data is available & collected at multiple timepoints over a 48 week follow-up period. Recruitment status for this study is 31 patients.



Access:
Closed to access
Type:
Disease specific
Status:
Completed
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Imaging data 0 - 3 months
Pathology records 0 - 3 months
Physiological/biochemical measurements 0 - 3 months
Quality indicators 0 - 3 months
Treatment records 0 - 3 months
Donor Ethnicity 0 - 3 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 75% -99%
Plasma -60°C to -85°C N/A Affected 75% -99%
RNA -60°C to -85°C N/A Affected 75% -99%
Serum -60°C to -85°C N/A Affected 75% -99%
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 75% -99%

Rheumatoid arthritis (disorder)

IRMA: Investigation of the Role of Microbiota in Arthritic Inflammation in DMARD-naïve Early Arthritis patients

Year Started: 2017

Observational, single site study. There are many reports that strongly suggest that certain bacteria living in the mouth and in the intestines of RA patients may cause and/or worsen RA. The purpose of the observational IRMA study is to identify RA patients who also have periodontitis (inflammation in their gums caused by bacteria) and compare them to healthy individuals. We will compare the presence of bacteria in the mouth with the RA disease activity and severity and investigate whether the presence of periodontitis and certain bacteria are related to the inflammation in joints and severity of RA disease. The long term goal is to determine if treating periodontitis, caused by certain bacteria, may help to improve the outcomes for patients with RA. Current recruitment status for this study is 12 patients.



Access:
Closed to access
Type:
Disease specific
Status:
In progress
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Freezer temperature logs 0 - 3 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Treatment records 3 - 6 months
Donor Ethnicity 3 - 6 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
DNA -60°C to -85°C N/A Affected 75% -99%
Faeces -60°C to -85°C N/A Affected 75% -99%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 75% -99%
Plasma -60°C to -85°C N/A Affected 75% -99%
RNA -60°C to -85°C N/A Affected 26 - 50%
Saliva -60°C to -85°C N/A Affected 75% -99%
Serum -60°C to -85°C N/A Affected 75% -99%
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 26 - 50%
Whole blood -60°C to -85°C N/A Affected 75% -99%